This guide provides instructions on how to set up and use CSV files with DBeaver. The CSV Pro driver allows you to work with CSV data as if it were in a database. You can retrieve data and apply ...

On February 2, wellness influencer Peter Attia stepped down from his role as chief science officer at the protein company David. On February 12, Goldman Sachs lawyer Kathryn Ruemmler announced her ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump and first lady Melania ...

The Karen Read case is mentioned in several FBI documents included in the latest tranche of files related to Jeffrey Epstein released by the federal government, though any connection between the two ...

The Karen Read case was mentioned in a 2024 FBI memo contained in the Justice Department’s latest release of Jeffrey Epstein files. The memo, dated June 4, 2024, was a roundup of various news stories ...

Reporters, lawmakers, and ordinary Americans are poring over a deluge of new files related to the Jeffrey Epstein case today, following the latest release from the Department of Justice. This release ...

The U.S. Department of Justice (DOJ) on Friday released millions of additional records from its investigative files on Jeffrey Epstein, expanding disclosures under a law designed to reveal what the ...

A federal judge denied a request for an independent monitor, saying he did not have the authority to supervise the Justice Department’s release of the documents. By Benjamin Weiser A federal judge on ...

To make it easier to pull a .csv or .txt file directly into Excel without having to deal with Power Query, Microsoft is introducing two new import functions. Microsoft is making two new Import ...

Baltimore Ravens kicker Tyler Loop has given a first emotional statement about his missed field goal, which crushed the team's playoff hopes. Loop had been having a good rookie season when the missed ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...